NCT06190275View on ClinicalTrials.gov

Clinical Study of GT201 in Combination with PD-1 Inhibitor for Advanced Head and Neck Tumors

NARecruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 12, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions

Adults

Interventions

BIOLOGICAL

GT201 in combination with PD-1 inhibitors

GT201 in combination with a PD-1 inhibitor for advanced head and neck tumors

Trial Locations (1)

200000

RECRUITING

Shanghai Ninth People's Hospital, Shanghai

Sponsors

Lead Sponsor

Grit Biotechnology

All Listed Sponsors

lead

Grit Biotechnology

INDUSTRY